Forward Pharma (FWP:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 49.440800 57252524 1.3014 1.0453 58.51 -27.09
LEXEA Liberty Expedia Holdings Inc 36.960000 57252524 0.9729 0.7814 58.51 -27.09
LTRPA Liberty TripAdvisor Holdings Inc 9.700000 75056405 97.0000 0.9263 10.30 0.40
PDLI PDL BioPharma Inc 2.420000 154338793 4.8400 0.4538 3.30 1.75
AXON Axovant Sciences Ltd 1.535000 107788074 None 1.5514 1.75 1.26
FWP Forward Pharma A/S 3.270000 47183999 2.5748 0.1314 28.75 0.96
OPHT Ophthotech Corp 2.760000 36038683 1.7468 2.2670 5.00 5.84
AGTC Applied Genetic Technologies Corp 3.850000 18104901 None 0.6247 3.89 0.44
APVO Aptevo Therapeutics Inc 3.150000 21428468 None 0.7474 3.54 2.72
VSAR Versartis Inc 1.800000 35809311 None 1.3090 3.32 3.17
APWC Asia Pacific Wire & Cable Corp Ltd 2.564000 13819669 7.5412 0.2401 3.54 0.44
GIGM GigaMedia Ltd 3.000000 11052235 None 0.5519 5.77 5.77
PTX Pernix Therapeutics Holdings Inc 2.260000 11797065 None None 2.31 -21.74
TNXP Tonix Pharmaceuticals Holding Corp 3.370000 7830040 None 0.9201 3.74 0.23
IPIC IPic Entertainment Inc 12.130000 12385629 None None 314.50 -14829.16
VLRX Valeritas Holdings Inc 3.050000 7132782 None 2.1984 4.78 -0.13
ABAC Renmin Tianli Group Inc 2.706800 7983745 24.6073 0.2442 7.56 7.30
CYCC Cyclacel Pharmaceuticals Inc 1.620000 11904521 None 0.8221 2.19 0.97
CREG China Recycling Energy Corp 2.020000 8310198 193.9950 0.0795 5.81 -0.21
ZSAN Zosano Pharma Corp 4.800000 1973046 None 0.6654 6.74 2.59
KBSF KBS Fashion Group Ltd 4.770000 1771132 None 0.1047 13.17 11.87
KONE Kingtone Wirelessinfo Solution Holding Ltd 3.860000 1405000 19.3000 0.2957 4.00 10.61
AVGR Avinger Inc 3.429800 877500 None None 11.59 -37.54
DCIX Diana Containerships Inc 2.510000 757193 None 0.0147 10.80 -26.46
HUNT Hunter Maritime Acquisition Corp 9.800000 4312500 None None 35.37 None

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

FWP:NAS Forward Pharma

http://www.forward-pharma.com
Forward Pharma has 12 employees and is headquartered in Denmark.
Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.

OPHT:NAS Ophthotech

http://www.ophthotechinc.com
Ophthotech has 156 employees and is headquartered in United States.
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.